Research Interest: Programmed Cell Death (PCD) in cardiovascular disease (CVD). While great progress has been achieved in the unveiling of the molecular mechanisms of PCD, a new level of complexity, with important therapeutic implications, has begun to emerge. I am particularly interested in Pyroptosis, a highly inflammatory form of lytic PCD, and Ferroptosis, a form of PCD involved in metabolic imbalance and the perturbation of redox homeostasis.